» Articles » PMID: 31406245

Akt Phosphorylation of Mitochondrial Lonp1 Protease Enables Oxidative Metabolism and Advanced Tumor Traits

Overview
Journal Oncogene
Date 2019 Aug 14
PMID 31406245
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor mitochondria have heightened protein folding quality control, but the regulators of this process and how they impact cancer traits are not completely understood. Here we show that the ATP-directed mitochondrial protease, LonP1 is upregulated by stress conditions, including hypoxia, in tumor, but not normal cells. In mitochondria, LonP1 is phosphorylated by Akt on Ser173 and Ser181, enhancing its protease activity. Interference with this pathway induces accumulation of misfolded subunits of electron transport chain complex II and complex V, resulting in impaired oxidative bioenergetics and heightened ROS production. Functionally, this suppresses mitochondrial trafficking to the cortical cytoskeleton, shuts off tumor cell migration and invasion, and inhibits primary and metastatic tumor growth, in vivo. These data identify LonP1 as a key effector of mitochondrial reprogramming in cancer and potential therapeutic target.

Citing Articles

Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer.

Yao M, Zhang X, Wu T, Feng T, Bian X, Abudurexiti M Cell Death Dis. 2025; 16(1):116.

PMID: 39971909 PMC: 11840119. DOI: 10.1038/s41419-025-07449-8.


Hypoxia-Induced Metabolic and Functional Changes in Oral CSCs: Implications for Stemness and Viability Modulation Through BNIP3-Driven Mitophagy.

Li X, Chaouhan H, Yu S, Wang I, Yu T, Chuang Y J Cell Mol Med. 2025; 29(3):e70400.

PMID: 39945227 PMC: 11822456. DOI: 10.1111/jcmm.70400.


The interconnective role of the UPS and autophagy in the quality control of cancer mitochondria.

Xu W, Dong L, Dai J, Zhong L, Ouyang X, Li J Cell Mol Life Sci. 2025; 82(1):42.

PMID: 39800773 PMC: 11725563. DOI: 10.1007/s00018-024-05556-x.


Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways.

Yuan S, Ou W, Mi X, Hou J PLoS One. 2024; 19(12):e0310825.

PMID: 39680520 PMC: 11649076. DOI: 10.1371/journal.pone.0310825.


A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications.

Zhang X, Fan Y, Tan K Cell Death Dis. 2024; 15(9):667.

PMID: 39261452 PMC: 11390889. DOI: 10.1038/s41419-024-07049-y.


References
1.
Pinti M, Gibellini L, Liu Y, Xu S, Lu B, Cossarizza A . Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer. Cell Mol Life Sci. 2015; 72(24):4807-24. PMC: 11113732. DOI: 10.1007/s00018-015-2039-3. View

2.
Gorrini C, Harris I, Mak T . Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12(12):931-47. DOI: 10.1038/nrd4002. View

3.
Pryde K, Taanman J, Schapira A . A LON-ClpP Proteolytic Axis Degrades Complex I to Extinguish ROS Production in Depolarized Mitochondria. Cell Rep. 2016; 17(10):2522-2531. PMC: 5177631. DOI: 10.1016/j.celrep.2016.11.027. View

4.
Balch W, Morimoto R, Dillin A, Kelly J . Adapting proteostasis for disease intervention. Science. 2008; 319(5865):916-9. DOI: 10.1126/science.1141448. View

5.
Sanchez-Alvarez M, del Pozo M, Bakal C . AKT-mTOR signaling modulates the dynamics of IRE1 RNAse activity by regulating ER-mitochondria contacts. Sci Rep. 2017; 7(1):16497. PMC: 5705697. DOI: 10.1038/s41598-017-16662-1. View